NYSE:PMC - PharMerica Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$29.25 0.00 (0.00 %)
(As of 06/22/2018 04:00 PM ET)
Previous Close$29.25
Today's Range$29.25 - $29.25
52-Week Range$22.00 - $29.50
VolumeN/A
Average Volume283,015 shs
Market Capitalization$910.27 million
P/E RatioN/A
Dividend YieldN/A
Beta0.82
PharMerica logoPharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.

Receive PMC News and Ratings via Email

Sign-up to receive the latest news and ratings for PMC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Distributors
SectorN/A
SymbolNYSE:PMC
CUSIP71714F10
Phone+1-502-6277000

Debt

Debt-to-Equity Ratio0.79
Current Ratio2.58
Quick Ratio1.79

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio15.23
P/E Growth1.27

Sales & Book Value

Annual Sales$2.09 billion
Price / Sales0.44
Cash Flow$3.8538 per share
Price / Cash7.59
Book Value$17.68 per share
Price / Book1.65

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$21.60 million
Net Margins0.54%
Return on Equity2.30%
Return on Assets1.02%

Miscellaneous

Employees5,700
Outstanding Shares31,120,000

The Truth About Cryptocurrencies

PharMerica (NYSE:PMC) Frequently Asked Questions

What is PharMerica's stock symbol?

PharMerica trades on the New York Stock Exchange (NYSE) under the ticker symbol "PMC."

How were PharMerica's earnings last quarter?

PharMerica Co. (NYSE:PMC) announced its quarterly earnings results on Thursday, November, 9th. The company reported $0.46 EPS for the quarter, missing analysts' consensus estimates of $0.49 by $0.03. The firm earned $595.10 million during the quarter, compared to analyst estimates of $596.80 million. PharMerica had a net margin of 0.54% and a return on equity of 2.30%. View PharMerica's Earnings History.

What price target have analysts set for PMC?

4 Wall Street analysts have issued 1 year target prices for PharMerica's shares. Their forecasts range from $29.25 to $29.25. On average, they expect PharMerica's share price to reach $29.25 in the next twelve months. View Analyst Ratings for PharMerica.

Who are PharMerica's key executives?

PharMerica's management team includes the folowing people:
  • Geoffrey G. Meyers, Independent Chairman of the Board (Age 72)
  • Gregory S. Weishar, Chief Executive Officer, Director (Age 62)
  • Suresh Vishnubhatla, Executive Vice President - Long-term Care Operations (Age 48)
  • Berard E. Tomassetti, Senior Vice President, Chief Accounting Officer (Age 61)
  • Thomas A. Caneris, Senior Vice President, General Counsel, Secretary (Age 54)
  • Robert A. McKay, Senior Vice President - Purchasing and Trade Relations (Age 55)
  • Frank E. Collins Esq., Independent Director (Age 63)
  • W. Robert Robert Dahl Jr., Independent Director (Age 60)
  • Marjorie W. Dorr, Independent Director (Age 55)
  • Patrick G. LePore, Independent Director (Age 62)

Has PharMerica been receiving favorable news coverage?

Media stories about PMC stock have been trending somewhat positive on Saturday, Accern Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. PharMerica earned a daily sentiment score of 0.10 on Accern's scale. They also gave news headlines about the company an impact score of 46.33 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of PharMerica?

Shares of PMC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PharMerica's stock price today?

One share of PMC stock can currently be purchased for approximately $29.25.

How big of a company is PharMerica?

PharMerica has a market capitalization of $910.27 million and generates $2.09 billion in revenue each year. PharMerica employs 5,700 workers across the globe.

How can I contact PharMerica?

PharMerica's mailing address is 1901 Campus Pl, LOUISVILLE, KY 40299-2308, United States. The company can be reached via phone at +1-502-6277000.


MarketBeat Community Rating for PharMerica (PMC)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  160 (Vote Outperform)
Underperform Votes:  232 (Vote Underperform)
Total Votes:  392
MarketBeat's community ratings are surveys of what our community members think about PharMerica and other stocks. Vote "Outperform" if you believe PMC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PMC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.